Three-Class Antiretroviral Resistance in a Patient with Acute HIV-1 Infection

No abstract is available for this paper.

• Publication year

  2006

• Venue

  AIDS Patients Care and STDs

• Publication date

  2006-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1089/apc.2006.20.741PMID 17134348
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management.

  2005cited by this paper
• Infection with multidrug resistant, dual-tropic HIV-1 and rapid progression to AIDS: a case report.

  2005cited by this paper
• Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1: 2003 recommendations of an International AIDS Society-USA Panel.

  2003cited by this paper
• European guidelines for the clinical management and treatment of HIV-infected adults in Europe.

  2003cited by this paper
• Antiretroviral-drug resistance among patients recently infected with HIV.

  2002cited by this paper
• Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel.

  2002cited by this paper
• Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents, January 28, 2000

  1998cited by this paper

• Transmission of triple‐class, drug‐resistant HIV‐1 in Australia

  2010cites this paper
• Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial.

  2009cites this paper
• Raltegravir with optimized background therapy for resistant HIV-1 infection.

  2008cites this paper